Sign Up to like & get
recommendations!
2
Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-97190-x
Abstract: RNA-based therapeutics are emerging as innovative options for cancer treatment, with microRNAs being attractive targets for therapy development. We previously implicated microRNA-642a-5p (miR-642a-5p) as a tumor suppressor in prostate cancer (PCa), and here we characterize…
read more here.
Keywords:
tumor suppressor;
cell cycle;
pca;
mir 642a ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of Oncology"
DOI: 10.1155/2022/8179208
Abstract: Colon adenocarcinoma (COAD) is the most common pathologic type of colon cancer. Metastasis is responsible for the high mortality rate of patients with COAD. The gene, metastasis-associated in colon cancer 1 (MACC1), is a biomarker…
read more here.
Keywords:
macc1;
cell infiltration;
immune cell;
mir 642a ... See more keywords